Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models

References

• Wang Q, Zhang L, Kuwahara K, et al. Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates. ACS Infect Dis. 2016 May 13;2(5):361–376. PubMed PMID: 27627203; PubMed Central PMCID: PMCPMC7075522. doi:https://doi.org/10.1021/acsinfecdis.6b00006.
   PubMed Web of Science ®Google Scholar
• Agrawal AS, Tao X, Algaissi A, et al. Immunization with inactivated Middle East respiratory syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus. Hum Vaccin Immunother. 2016 Sep;12(9):2351–2356. PubMed PMID: 27269431; PubMed Central PMCID: PMCPMC5027702. doi:https://doi.org/10.1080/21645515.2016.1177688.
   PubMed Web of Science ®Google Scholar
• Gao Q, Bao L, Mao H, et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020 Jul 3;369(6499):77–81. PubMed PMID: 32376603; PubMed Central PMCID: PMCPMC7202686. doi:https://doi.org/10.1126/science.abc1932.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang Y, Huang B, et al. Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2. Cell. 2020 Aug 6;182(3):713–721 e9. PubMed PMID: 32778225; PubMed Central PMCID: PMCPMC7275151. doi:https://doi.org/10.1016/j.cell.2020.06.008.
   PubMed Web of Science ®Google Scholar
• Choe PG, Kang CK, Suh HJ, et al. Waning antibody responses in asymptomatic and symptomatic SARS-CoV-2 infection. Emerg Infect Dis. 2021 Jan;27(1). PubMed PMID: 33050983; PubMed Central PMCID: PMCPMC7774548. doi:https://doi.org/10.3201/eid2701.203515.
   Google Scholar
• Seow J, Graham C, Merrick B, et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans. Nat Microbiol. 2020 Dec;5(12):1598–1607. PubMed PMID: 33106674; PubMed Central PMCID: PMCPMC7610833. doi:https://doi.org/10.1038/s41564-020-00813-8.
   PubMed Web of Science ®Google Scholar
• Houser KV, Broadbent AJ, Gretebeck L, et al. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody. PLoS Pathog. 2017 Aug;13(8):e1006565), PubMed PMID: 28817732; PubMed Central PMCID: PMCPMC5574614. doi:https://doi.org/10.1371/journal.ppat.1006565.
   Web of Science ®Google Scholar
• Wang SF, Tseng SP, Yen CH, et al. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. Biochem Biophys Res Commun. 2014 Aug 22;451(2):208–214. PubMed PMID: 25073113; PubMed Central PMCID: PMCPMC7092860. doi:https://doi.org/10.1016/j.bbrc.2014.07.090.
   PubMed Web of Science ®Google Scholar
• Shan C, Yao YF, Yang XL, et al. Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in rhesus macaques. Cell Res. 2020 Aug;30(8):670–677. PubMed PMID: 32636454; PubMed Central PMCID: PMCPMC7364749. doi:https://doi.org/10.1038/s41422-020-0364-z.
   PubMed Web of Science ®Google Scholar
• Che Y, Liu X, Pu Y, et al. Randomized, double-blinded and placebo-controlled phase II trial of an inactivated SARS-CoV-2 vaccine in healthy adults. Clin Infect Dis. 2020 Nov 9. PubMed PMID: 33165503; PubMed Central PMCID: PMCPMC7717222. doi:https://doi.org/10.1093/cid/ciaa1703.
   Google Scholar
• Dong C, Liu L, Zhao H, et al. Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine. 2011 Aug 26;29(37):6269–6275. PubMed PMID: 21722686. doi:https://doi.org/10.1016/j.vaccine.2011.06.044.
   PubMed Web of Science ®Google Scholar
• Dong C, Wang J, Liu L, et al. Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys. Hum Vaccin. 2010 Dec;6(12):1028–1037. PubMed PMID: 21150270. doi:https://doi.org/10.4161/hv.6.12.12982.
   PubMed Web of Science ®Google Scholar
• Ibarrondo FJ, Fulcher JA, Goodman-Meza D, et al. Rapid decay of anti-SARS-CoV-2 antibodies in persons with mild covid-19. N Engl J Med. 2020 Sep 10;383(11):1085–1087. PubMed PMID: 32706954; PubMed Central PMCID: PMCPMC7397184. doi:https://doi.org/10.1056/NEJMc2025179.
   PubMed Web of Science ®Google Scholar
• Wang GL, Wang ZY, Duan LJ, et al. Susceptibility of circulating SARS-CoV-2 variants to neutralization. N Engl J Med. 2021 Jun 17;384(24):2354–2356. PubMed PMID: 33822491; PubMed Central PMCID: PMCPMC8063885. doi:https://doi.org/10.1056/NEJMc2103022.
   PubMed Web of Science ®Google Scholar
• Muena NA, García-Salum T, Pardo-Roa C, et al. Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines. medRxiv. 2021 2021-01-01 00:00:00.
   Google Scholar
• Zheng J, Wang Y, Li K, et al. Severe acute respiratory syndrome coronavirus 2-induced immune activation and death of monocyte-derived human macrophages and dendritic cells. J Infect Dis. 2021 Mar 3;223(5):785–795. PubMed PMID: 33277988; PubMed Central PMCID: PMCPMC7799009. doi:https://doi.org/10.1093/infdis/jiaa753.
   Web of Science ®Google Scholar